PRPO on Nasdaq

Precipio, Inc.

American laboratory analytical instruments company based in New Haven.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with BioNano Genomics, EyePoint Pharmaceuticals or RAPID MICRO BIOSYSTEMS, INC., or pick any stock.

  • TickerPRPO on Nasdaq
  • IndustryLaboratory Analytical Instruments
  • HeadquartersNew Haven, United States
  • Incorporated inDE2
  • Business address4 Science Park, New Haven, Ct 065112
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

44.2%Gross margin3
-5.0%Operating margin3
-1.5%Net margin3
30.5%Revenue growth, 20253
-2.5%Return on equity3
0.00×Debt to equity3
$359.0KFree cash flow3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Service revenue, net brought in 89% of the revenue Precipio, Inc. broke down this way in fiscal 2025.

  1. Service revenue, net$21.5M389%up 35% from 2024
  2. Product$2.7M311%up 5% from 2024
Products and services by year
Products and services20242025
Service revenue, net$16.0M$21.5M
Product$2.6M$2.7M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue55¢$13.3M
  • Research and development7¢$1.6M
  • Other costs38¢$9.3M

Out of $24.2M in revenue.3 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending48¢$326.0K
  • Kept or used elsewhere52¢$359.0K

Out of $685.0K of cash from operations.3

Financial statements

Revenue456783$24.2M in 2025+492% since 2019
0$10.0M$20.0M$30.0M2019: $4.1M$4.1M20192020: $7.4M$7.4M2020+81%2021: $8.7M$8.7M2021+17%2022: $9.8M$9.8M2022+13%2023: $15.4M$15.4M2023+57%2024: $18.6M$18.6M2024+21%2025: $24.2M$24.2M2025+31%
Gross profit456783$10.7M in 2025+4789% since 2019
0$5.0M$10.0M$15.0M2019: $219.0K$219.0K20192020: $1.1M$1.1M2020+425%2021: $2.4M$2.4M2021+108%2022: $2.5M$2.5M2022+5%2023: $6.0M$6.0M2023+140%2024: $7.6M$7.6M2024+26%2025: $10.7M$10.7M2025+42%
Operating income456783-$1.2M in 2025−89% since 2019
-$15.0M-$10.0M-$5.0M02019: -$11.0M-$11.0M20192020: -$9.1M-$9.1M2020−17%2021: -$9.6M-$9.6M2021+5%2022: -$12.8M-$12.8M2022+33%2023: -$7.6M-$7.6M2023−40%2024: -$4.2M-$4.2M2024−45%2025: -$1.2M-$1.2M2025−71%
Net income956783-$363.0K in 2025−97% since 2019
-$15.0M-$10.0M-$5.0M02019: -$13.2M-$13.2M20192020: -$10.6M-$10.6M2020−20%2021: -$8.5M-$8.5M2021−20%2022: -$12.2M-$12.2M2022+43%2023: -$5.9M-$5.9M2023−52%2024: -$4.3M-$4.3M2024−27%2025: -$363.0K-$363.0K2025−92%

Every line of the income statement as filed: the last 2 fiscal years, latest first.3

Period ending2025-12-312024-12-31
Revenue, net of contractual allowances and adjustments$24.2M$18.6M
Adjustment for allowance for credit losses-$197.0K-$44.0K
Net sales$24.0M$18.5M
Total cost of sales$13.3M$11.0M
Gross profit$10.7M$7.6M
Operating expenses$11.9M$11.8M
OPERATING LOSS-$1.2M-$4.2M
Interest expense, net-$73.0K-$74.0K
Gain on settlement of liability$143.0K
Employee Retention Credit$789.0K
Other expense-$20.0K
Total other income (expense)$839.0K-$74.0K
LOSS BEFORE INCOME TAXES-$363.0K-$4.3M
INCOME TAX EXPENSE$0$0
NET LOSS-$363.0K-$4.3M
BASIC LOSS PER COMMON SHARE-$0.23-$2.93
BASIC WEIGHTED-AVERAGE SHARES OF COMMON STOCK OUTSTANDING1.6M shares1.5M shares
DILUTED LOSS PER COMMON SHARE-$0.23-$2.93
DILUTED WEIGHTED-AVERAGE SHARES OF COMMON STOCK OUTSTANDING1.6M shares1.5M shares

Compare Precipio, Inc. with another company

Leadership

Who has led Precipio, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (28)

Former names

  • TRANSGENOMIC INCMar 10, 2000 to Jun 30, 20172

Timeline

  1. Jul 3, 2017New chief executive Ilan Danieli becomes CEO12
  2. Oct 3, 2013New chief executive Paul Kinnon becomes CEO13
  3. Jul 13, 2006New chief executive Craig James Tuttle becomes CEO14
  4. Jul 10, 2000Founded Precipio, Inc. is founded49

Filings

250 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 50 major events, 138 insider forms, 4 large holders, 38 other. The latest 20:

  1. Aug 14, 20268-K EDGAR
  2. Aug 14, 202610-Q EDGAR
  3. Jul 31, 20268-K EDGAR
  4. Jul 16, 20264 OWNERSHIP DOCUMENT EDGAR
  5. Jul 16, 20264 OWNERSHIP DOCUMENT EDGAR
  6. Jul 16, 20264 OWNERSHIP DOCUMENT EDGAR
  7. Jun 15, 20268-K EDGAR
  8. May 26, 20264 OWNERSHIP DOCUMENT EDGAR
  9. May 21, 20264 OWNERSHIP DOCUMENT EDGAR
  10. May 19, 2026144 EDGAR
  11. May 14, 202610-Q EDGAR
  12. May 6, 20268-K EDGAR
  13. Apr 28, 2026ARS EDGAR
  14. Apr 28, 2026DEFA14A EDGAR
  15. Apr 28, 2026DEF 14A EDGAR
  16. Apr 17, 20264 OWNERSHIP DOCUMENT EDGAR
  17. Apr 17, 20264 OWNERSHIP DOCUMENT EDGAR
  18. Apr 17, 20264 OWNERSHIP DOCUMENT EDGAR
  19. Apr 10, 20264 OWNERSHIP DOCUMENT EDGAR
  20. Mar 30, 202610-K EDGAR

The 250 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 4 such filings since October 2021:

  1. Feb 10, 2026SCHEDULE 13G/A
  2. Oct 21, 2025SCHEDULE 13G/A
  3. Sep 22, 2025SCHEDULE 13G
  4. Aug 2, 2024SC 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Vanguard Capital Management LLC46,148$1.1M0.0%+20,665
BlackRock, Inc.34,655$858.1K0.0%+5,633
Geode Capital Management, LLC18,691$462.9K0.0%−120
Renaissance Technologies LLC16,199$401.1K0.0%−3,101
Citadel Advisors LLC14,714$364.3K0.0%−402
XTX Topco Ltd9,450$234.0K0.0%New
Vanguard Fiduciary Trust Co9,407$232.9K0.0%+62
Dimensional Fund Advisors LP8,396$207.9K0.0%New
UBS Group AG343$8.5K0.0%+116
Wells Fargo & Company/mn50$1.2K0.0%No change
Tower Research Capital LLC (TRC)32$7920.0%−106
Morgan Stanley7$1730.0%New
Allworth Financial LP3$750.0%No change
IFP Advisors, Inc3$740.0%No change
Fmr LLC2$540.0%No change
Citigroup Inc1$250.0%New
Caitong International Asset Management Co., Ltd1$250.0%New
Royal Bank Of Canada11$00.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49